PCR Amplicon sequencing enables cost-effective target enrichment and sequencing with rapid turnaround, flexibility, and scalability. WBL’s Service leverages ONT’s long read sequencing, enabling long reads for full amplicon analysis and real-time data acquisition.
Applications of amplicon sequencing encompass a wide range of uses, such as profiling antibodies, genotyping diseases, analyzing CRISPR-induced mutations, sequencing target genes, evaluating molecular clones, and assessing plasmid stocks.
WBL’s technology leverages the power of Nanopore long reads. Now equipped with clinically-viable sequencing accuracy and yield, long-read technologies are positioned to advance research and clinical diagnostics.
Long read PCR amplicon sequencing is particularly advantageous when investigating genomic regions that are challenging to sequence with short-read approaches. These include highly repetitive regions, structural variations, and other complexities.
*WBL currently only accepts DNA and RNA that are extracted from samples that are not classified as infectious. This policy ensures the safety of our laboratory personnel and compliance with regulatory standards. Please ensure that all samples are appropriately treated and certified as non-infectious before submission. If you have any questions about sample preparation or our safety standards, please contact our support team at: support@wasatchbiolabs.com.
Maximize your sequencing output with WBL’s leading technology, streamlined bioinformatics pipelines, and expert guidance. WBL’s team of researchers are pioneers in Oxford Nanopore Technologies sequencing with decades of experience in genomics and bioinformatics research.
NGS 3.0 data with fully streamlined bioinformatics pipelines.
Results within 14-21 days of your sample’s arrival at the lab.
Teams of dedicated researchers and project managers to support your research and development.
Direct access to an online portal for sample information and batch status at each step of the sequencing process.
